Foresight’s deep-tech ventures team is the lead-investor amongst other eminent institutional investors SenseAI, a spin-out from the University of Liverpool, is developing world-leading ‘compressive sensing’ technology that will enhance the performance of analytical equipment including electron microscopes by up to 100x The investment will supercharge SenseAI’s product development and roll-out to research and industrial customers […]

A Wyoming startup is shedding light on one of agriculture’s most expensive blind spots by turning every tractor into a real-time soil lab. LARAMIE, WY — Fertilizer is the biggest input cost in agriculture, and soil fertility is the least understood. Despite billions spent each year, most growers are still flying blind beneath the surface. They […]

Believes Years of Self-Inflicted Issues Have Caused Avantor to Trade at a Meaningful Discount to its Intrinsic Value and Life Sciences Peers Contends the Board Has Failed to Remedy Operating Underperformance, Ineffective Cost Controls and Poor Capital Deployment – Resulting in Significant Value Destruction Over Every Relevant Period Makes Clear the Board Needs to Be […]

Emmanuel Ligner, Seasoned Leader with Proven Track Record of Value Creation in Life Sciences, to Begin Role as CEO Next Week RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today issued the following statement in response to the […]

Investment to Drive Commercial Growth, Advance Single-Cell Tri-omics Capabilities and Clinical Applications Across Cancer Company Adds to Leadership Team, with Matthew H. Cato Joining as CCO SOUTH SAN FRANCISCO, Calif. – Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, today announced the successful completion of equity financing led by Ally Bridge Group. […]

SEATTLE — Pluristyx, a leading provider of induced pluripotent stem cell (iPSC) technologies and proprietary gene editing solutions, today announced the successful close of its most recent round of funding led by BioLife Solutions, the global leader in cryopreservation technologies and systems that support cell and gene therapy (CGT) manufacturing, and BroadOak Capital Partners, a […]

eattle, Washington – Pluristyx, a leading provider of induced pluripotent stem cell (iPSC) technologies and proprietary gene editing solutions, today announced the successful close of its most recent round of funding led by BioLife Solutions, the global leader in cryopreservation technologies and systems that support cell and gene therapy (CGT) manufacturing, and BroadOak Capital Partners, […]

DÜSSELDORF, Germany – LenioBio GmbH has been awarded EU4Health funding by the European Health and Digital Executive Agency (HaDEA), which implemented the corresponding call for proposals on behalf of the European Commission’s Health Emergency Preparedness and Response Authority (HERA). The project will focus on further development of the cell-free protein expression system, ALiCE®, as an innovative, […]

Funding commitment makes Veralto a Cornerstone Investor of the new proposed fund, expected to launch in October WALTHAM, Mass. — Veralto Corporation (NYSE: VLTO) (the “Company”), a global leader in essential water and product quality solutions dedicated to Safeguarding the World’s Most Vital Resources™, announced a €20 million investment commitment in Emerald Technology Ventures’ Global […]

Proceeds will accelerate Optibrium’s product development and expand the global reach of its computational chemistry and AI-driven discovery technology CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for molecular design, today announced it has secured a strategic financing package with Shawbrook, a specialist UK bank that provides finance to established UK businesses on high […]